按首字母搜索

Cas号索引 1

• 1439399-58-2 | CB-839 (Catalog# : 16122913)CB-839 an is orally bioavailable inhibitor of glutaminase, with potential antineoplas
• 1477949-42-0 | CAY10683 (Catalog# : 16122912)CAY10683, also known as Santacruzamate A, is a potent and selective histone deacetyla
• 1049741-55-0 | Cardiogenol C HCl (Catalog# : 16122911)Cardiogenol C is a diaminopyrimidine compound that induces the differentiation of MHC
• 193273-69-7 | Capromorelin tartrate (Catalog# : 16122910)Capromorelin, also known as CP-424,391, is a growth hormone secretagogue and ghrelin
• 1380087-89-7 | CPI-0610 (Catalog# : 16122738)CPI-0610 is a potent and selective benzoisoxazoloazepine BET bromodomain inhibitor an
• 1884712-47-3 | CPI-637 (Catalog# : 16122737)CPI-637 is a selective and cell-active benzodiazepinone CBP/EP300 bromodomain inhibit
• 1790895-25-8 | CeMMEC13 (Catalog# : 6111701)CeMMEC13 is an isoquinolinone that selectively inhibits the second bromodomain of TAF
• 1429239-98-4 | CB1-IN-1 (Catalog# : 6111108)CB1-IN-1 is a peripherally restricted CB1R antagonist, with Ki of 0.3 nM and 21 nM fo
• 1228780-72-0 | 1-{[2-(4-chlorophenyl)-4,4-dimethylcyclohex-1-en-1-yl]methyl}piperazine (Catalog# : 61110004)1-{[2-(4-chlorophenyl)-4,4-dimethylcyclohex-1-en-1-yl]methyl}piperazine
• 1319207-44-7 | CC0651 (Catalog# : 611933)CC0651 is an allosteric inhibitor of the human cdc34 ubiquitin-conjugating enzyme tha
• 1421693-22-2 | CDKI-73 (Catalog# : 611920)CDKI-73 is a potent CDK9 inhibitor with Ki of 4 nM; shows selective toxicity to CLL c
• 1391855-95-0 | CDK9-IN-6 (Catalog# : 611919)CDK9-IN-6 is a CDK9 inhibitor, refers to Example 399 in WO 2012101062 A1
• 1402821-24-2 | Ca2+ channel agonist 1 (Catalog# : 611918)Ca2+ channel agonist 1 is a N-type Ca2+ channel activity agonist, with EC50 of 14.23
• 1309357-15-0 | CX-4945 sodium salt (Catalog# : 611912)CX-4945 (Silmitasertib) sodium salt is a potent and selective ATP-competitive small m
• 1431697-78-7 | CAL-130 Hydrochloride (Catalog# : 611823)CAL-130 Hcl is a novel phosphoinositide 3-kinase (PI3K) inhibitor. It is reported tha
• 1431697-74-3 | CAL-130 (Catalog# : 611822)CAL-130 is a novel phosphoinositide 3-kinase (PI3K) inhibitor. It is reported that co
• 168425-64-7 | Compound 401 (Catalog# : 611816)Compound 401 is a synthetic inhibitor of DNA-PK (IC50 = 0.28 M) that also targets mTO
• 1300118-55-1 | CC-115 hydrochloride (Catalog# : 611815)CC-115 hydrochloride is a inhibitor of mTOR/DNA-PK (IC50= 21/ 13 nM). CC-115 shows go
• 1218777-13-9 | CAY10505 (Catalog# : 160926016)CAY10505 is a phosphatidylinositol 3-kinase- inhibitor , was found to significantly i
• 1007207-67-1 | CH5132799 (PA-799) (Catalog# : 160926015)CH5132799, also known as PA-799, is a novel class I PI3K inhibitor, which exhibited a
• 1489389-18-5 | CCT245737 (Catalog# : 16090101)CCT245737(CCT-245737, CAS 1489389-18-5) is the first orally active, clinical developm
• 1564286-55-0 | CWHM-12 (Catalog# : 16071407)vitro ligand-binding assays, with somewhat less potency against v5 than against the o
• 1032568-63-0 | Copanlisib (Catalog# : 16070917)Copanlisib, also known as BAY 80-6946, is a phosphoinositide 3-kinase (PI3K) inhibito
• 1404095-34-6 | CCT244747 (Catalog# : 16070913)CCT244747 is a novel potent, highly selective, orally active ATP-competitive CHK1 inh
• 134448-10-5 | CA-074 (Catalog# : 16062115)CA-074
• 163042-96-4 | CF-102 (Catalog# : 16053104)CF-102, also known as 2-Cl-IB-MECA, is an orally bioavailable, synthetic, highly sele
• 156177-65-0 | CEP-1347 (Catalog# : 032402)Coming soon!
• 1446144-04-2 | CPI-203 (Catalog# : 030201)CPI 203 is a novel potent, selective and cell permeable inhibitor of the bromodomain
• 194423-06-8 | CL-387785 (Catalog# : 022202)CL-387785 is an irreversible inhibitor of EGFR with IC50 of 370+/-120 pM; is able to
• 1228013-30-6 | CC-223 (Catalog# : 021802)CC-223 is a potent mTOR kinase inhibitor (IC50=16 nM), with >150-fold sensitivity